Eight CD34-negative AML cases were treated with and without DEAB and in these we analysed the ALDH activity MFI level of the CD34+CD38– HSC, defined by lack of immunophenotypic marker expression, and the ALDH activity MFI level of the CD34– cells. This evidence concerns the gene CD38 and acute myeloid leukemia.